

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.33272954 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.27459081 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.26935461 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.73754467 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.73754467 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.38454896 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.38454896 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.89144716 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26246462 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.24360162 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.24360162 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.24360162 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.07664472 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.90430525 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.89469575 |
| 16 | drug metabolic process (GO:0017144) | 5.86913234 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.76082564 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 5.64807255 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55246815 |
| 20 | urea metabolic process (GO:0019627) | 5.52106166 |
| 21 | urea cycle (GO:0000050) | 5.52106166 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.48274426 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.47799432 |
| 24 | regulation of plasminogen activation (GO:0010755) | 5.40548891 |
| 25 | oxidative demethylation (GO:0070989) | 5.39590489 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.38575232 |
| 27 | protein carboxylation (GO:0018214) | 5.36597918 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36597918 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.29104070 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.25822607 |
| 31 | cysteine metabolic process (GO:0006534) | 5.25186204 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.23286077 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.08162224 |
| 34 | bile acid metabolic process (GO:0008206) | 5.06961545 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.03168962 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.02947805 |
| 37 | ethanol metabolic process (GO:0006067) | 4.91549726 |
| 38 | regulation of complement activation (GO:0030449) | 4.91310564 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88284128 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.86443757 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.79896131 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.77820840 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.75379386 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.72819512 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.72819512 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.68346739 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.68346739 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.68346739 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.67138681 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.63498418 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.59928439 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.59928439 |
| 53 | lysine catabolic process (GO:0006554) | 4.56072229 |
| 54 | lysine metabolic process (GO:0006553) | 4.56072229 |
| 55 | phospholipid efflux (GO:0033700) | 4.54212614 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.53603614 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.53603614 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.50043987 |
| 59 | acute-phase response (GO:0006953) | 4.48988105 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.48513528 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.47750118 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.46732684 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.41520389 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.33817990 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 4.31792591 |
| 66 | amine catabolic process (GO:0009310) | 4.31792591 |
| 67 | regulation of humoral immune response (GO:0002920) | 4.30061538 |
| 68 | glycine metabolic process (GO:0006544) | 4.29643668 |
| 69 | glutamate metabolic process (GO:0006536) | 4.29409201 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.28745093 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.26271387 |
| 72 | cholesterol efflux (GO:0033344) | 4.18470515 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.17204416 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 4.15864429 |
| 75 | negative regulation of wound healing (GO:0061045) | 4.15184164 |
| 76 | alkaloid metabolic process (GO:0009820) | 4.12195956 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.12163876 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 4.11568345 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 4.10105625 |
| 80 | cellular glucuronidation (GO:0052695) | 4.08769654 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.08615980 |
| 82 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.04972726 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 3.99933170 |
| 84 | positive regulation of hemostasis (GO:1900048) | 3.99933170 |
| 85 | ethanol oxidation (GO:0006069) | 3.96484014 |
| 86 | fibrinolysis (GO:0042730) | 3.96081728 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.94750190 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92501721 |
| 89 | arginine metabolic process (GO:0006525) | 3.91339023 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.91151216 |
| 91 | drug catabolic process (GO:0042737) | 3.91066855 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.90337810 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.88752355 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87214019 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.84630856 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83332064 |
| 97 | ketone body metabolic process (GO:1902224) | 3.81922216 |
| 98 | cofactor catabolic process (GO:0051187) | 3.78971348 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78645657 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78645657 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.74266322 |
| 102 | organic acid catabolic process (GO:0016054) | 3.73029365 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.73029365 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72520051 |
| 105 | cholesterol homeostasis (GO:0042632) | 3.70274786 |
| 106 | protein activation cascade (GO:0072376) | 3.68759674 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.67862347 |
| 108 | complement activation (GO:0006956) | 3.66718666 |
| 109 | intestinal cholesterol absorption (GO:0030299) | 3.65667101 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.65384028 |
| 111 | positive regulation of coagulation (GO:0050820) | 3.65209814 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.64753827 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.64150408 |
| 114 | sterol homeostasis (GO:0055092) | 3.64147319 |
| 115 | cytolysis (GO:0019835) | 3.64030694 |
| 116 | uronic acid metabolic process (GO:0006063) | 3.62167314 |
| 117 | glucuronate metabolic process (GO:0019585) | 3.62167314 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.61221138 |
| 119 | regulation of lipoprotein particle clearance (GO:0010984) | 3.59156606 |
| 120 | opsonization (GO:0008228) | 3.59058826 |
| 121 | plasma lipoprotein particle organization (GO:0071827) | 3.57058362 |
| 122 | NAD biosynthetic process (GO:0009435) | 3.54660369 |
| 123 | negative regulation of complement activation (GO:0045916) | 3.54595047 |
| 124 | protein-lipid complex assembly (GO:0065005) | 3.51861650 |
| 125 | acute inflammatory response (GO:0002526) | 3.48568885 |
| 126 | heme transport (GO:0015886) | 3.44259571 |
| 127 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.39605518 |
| 128 | flavonoid metabolic process (GO:0009812) | 3.39179160 |
| 129 | protein-lipid complex subunit organization (GO:0071825) | 3.37682105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42881200 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19313334 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.88384654 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50464302 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.37710482 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13627713 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.67370913 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.11163700 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09133357 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06582687 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8807138 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98830611 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98706076 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61603771 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52532340 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47827240 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41124491 |
| 18 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38865837 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31000273 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21873401 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20696423 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20387333 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07432352 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04090514 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96273987 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95650584 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93147116 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91585090 |
| 29 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91157259 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89437631 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89397430 |
| 32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88669362 |
| 33 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.86198211 |
| 34 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84896114 |
| 35 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.84377168 |
| 36 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84242274 |
| 37 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83967589 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82574307 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81247157 |
| 40 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80739361 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79784772 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79438324 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79347300 |
| 44 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78885539 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77751753 |
| 46 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77667658 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77077939 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76797426 |
| 49 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75877693 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.73617425 |
| 51 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73472694 |
| 52 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73432648 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72997906 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72762468 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71339651 |
| 56 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71223704 |
| 57 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70846025 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69936789 |
| 59 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69478401 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69211973 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.68697066 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.68391362 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67884443 |
| 64 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67205978 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 0.67023911 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66859709 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66058517 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66021959 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65852131 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.63852260 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62948400 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62481309 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62442494 |
| 74 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.62319693 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.61936337 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61870093 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61352550 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61063127 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.60512008 |
| 80 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.60441909 |
| 81 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.60433544 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 0.60422041 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60091534 |
| 84 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.60036314 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59531101 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59531101 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59372839 |
| 88 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.59071121 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.59071121 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58991457 |
| 91 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.58861013 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.58378513 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57792465 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57540428 |
| 95 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57276346 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56931262 |
| 97 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.56930114 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55914384 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55807990 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55780811 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.55636197 |
| 102 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55494159 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55221016 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53794033 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52777658 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52618563 |
| 107 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49891919 |
| 108 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48556515 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48164637 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47530598 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47145681 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47041942 |
| 113 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46797614 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46215423 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44415273 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44047571 |
| 117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.43731439 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42546555 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42516585 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42275228 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42273564 |
| 122 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42135936 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42029400 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41905024 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41234411 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41003457 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40973750 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40924606 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40019719 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38998368 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37636521 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37614360 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37400415 |
| 134 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37335711 |
| 135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36968959 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36419309 |
| 137 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35817141 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.35739444 |
| 139 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35616839 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35481942 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.35329833 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.34483851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.32364370 |
| 2 | MP0005360_urolithiasis | 7.35879133 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46615457 |
| 4 | MP0005365_abnormal_bile_salt | 6.17544950 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10705288 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19018986 |
| 7 | MP0003252_abnormal_bile_duct | 4.02097965 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.46506388 |
| 9 | MP0009840_abnormal_foam_cell | 3.30721352 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10510403 |
| 11 | MP0003195_calcinosis | 3.10275094 |
| 12 | MP0005332_abnormal_amino_acid | 2.76209963 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.62900157 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.33897467 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19239817 |
| 16 | * MP0002118_abnormal_lipid_homeostasis | 2.13380212 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.13096537 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.97537163 |
| 19 | MP0003868_abnormal_feces_composition | 1.96662140 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80857394 |
| 21 | MP0001764_abnormal_homeostasis | 1.64675443 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54099815 |
| 23 | MP0009697_abnormal_copulation | 1.48376973 |
| 24 | MP0005451_abnormal_body_composition | 1.42780845 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.31346583 |
| 26 | MP0003011_delayed_dark_adaptation | 1.28569093 |
| 27 | MP0003186_abnormal_redox_activity | 1.20124509 |
| 28 | MP0000598_abnormal_liver_morphology | 1.17898501 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.17069817 |
| 30 | MP0002132_abnormal_respiratory_system | 1.16482970 |
| 31 | MP0005647_abnormal_sex_gland | 1.12999825 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.07915779 |
| 33 | MP0003879_abnormal_hair_cell | 1.04046867 |
| 34 | MP0000604_amyloidosis | 1.02847053 |
| 35 | MP0009764_decreased_sensitivity_to | 1.02441915 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.01216279 |
| 37 | MP0009763_increased_sensitivity_to | 0.99700682 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.98568363 |
| 39 | MP0002254_reproductive_system_inflammat | 0.96069597 |
| 40 | MP0005220_abnormal_exocrine_pancreas | 0.95807695 |
| 41 | MP0005408_hypopigmentation | 0.90864755 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.89944925 |
| 43 | * MP0002078_abnormal_glucose_homeostasis | 0.89534891 |
| 44 | MP0008469_abnormal_protein_level | 0.86532599 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 0.85741665 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.85026867 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.84951781 |
| 48 | MP0005670_abnormal_white_adipose | 0.82566388 |
| 49 | MP0001986_abnormal_taste_sensitivity | 0.82148752 |
| 50 | MP0005187_abnormal_penis_morphology | 0.80991280 |
| 51 | MP0005376_homeostasis/metabolism_phenot | 0.77065427 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.76023179 |
| 53 | MP0005535_abnormal_body_temperature | 0.73425413 |
| 54 | MP0002282_abnormal_trachea_morphology | 0.71119662 |
| 55 | MP0003283_abnormal_digestive_organ | 0.71016127 |
| 56 | MP0003878_abnormal_ear_physiology | 0.70295372 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 0.70295372 |
| 58 | MP0001661_extended_life_span | 0.70009111 |
| 59 | * MP0005334_abnormal_fat_pad | 0.66286144 |
| 60 | MP0002249_abnormal_larynx_morphology | 0.65492453 |
| 61 | MP0004130_abnormal_muscle_cell | 0.64977661 |
| 62 | MP0001756_abnormal_urination | 0.64719727 |
| 63 | MP0005266_abnormal_metabolism | 0.63869384 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.62194221 |
| 65 | MP0003329_amyloid_beta_deposits | 0.61617329 |
| 66 | MP0003690_abnormal_glial_cell | 0.61526215 |
| 67 | * MP0002971_abnormal_brown_adipose | 0.60856719 |
| 68 | MP0002928_abnormal_bile_duct | 0.60738513 |
| 69 | MP0005448_abnormal_energy_balance | 0.59851783 |
| 70 | MP0009053_abnormal_anal_canal | 0.58752418 |
| 71 | MP0002909_abnormal_adrenal_gland | 0.57060948 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.55986267 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.54004146 |
| 74 | MP0001915_intracranial_hemorrhage | 0.53995535 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.53228133 |
| 76 | MP0004883_abnormal_blood_vessel | 0.52509489 |
| 77 | MP0002090_abnormal_vision | 0.50930172 |
| 78 | MP0004510_myositis | 0.50290762 |
| 79 | MP0009785_altered_susceptibility_to | 0.49412458 |
| 80 | MP0005395_other_phenotype | 0.48523632 |
| 81 | * MP0003953_abnormal_hormone_level | 0.48058992 |
| 82 | MP0005164_abnormal_response_to | 0.48033077 |
| 83 | MP0003724_increased_susceptibility_to | 0.47657094 |
| 84 | MP0000579_abnormal_nail_morphology | 0.46708462 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.46262135 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.45180368 |
| 87 | MP0002822_catalepsy | 0.44149184 |
| 88 | MP0003718_maternal_effect | 0.43941413 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.42153016 |
| 90 | MP0008874_decreased_physiological_sensi | 0.41988452 |
| 91 | MP0004043_abnormal_pH_regulation | 0.41902903 |
| 92 | MP0008873_increased_physiological_sensi | 0.41755979 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.41506947 |
| 94 | MP0003436_decreased_susceptibility_to | 0.41243025 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.40657671 |
| 96 | MP0009672_abnormal_birth_weight | 0.39053432 |
| 97 | MP0003075_altered_response_to | 0.39015322 |
| 98 | * MP0001944_abnormal_pancreas_morphology | 0.37936268 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.37457079 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.37252489 |
| 101 | MP0005166_decreased_susceptibility_to | 0.35140494 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.34479055 |
| 103 | MP0002970_abnormal_white_adipose | 0.33803519 |
| 104 | MP0004381_abnormal_hair_follicle | 0.33436548 |
| 105 | MP0001243_abnormal_dermal_layer | 0.32690052 |
| 106 | MP0002168_other_aberrant_phenotype | 0.32607149 |
| 107 | MP0009115_abnormal_fat_cell | 0.31870315 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.30612623 |
| 109 | MP0006082_CNS_inflammation | 0.30492239 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.29696989 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.29696989 |
| 112 | MP0001502_abnormal_circadian_rhythm | 0.29379739 |
| 113 | MP0008872_abnormal_physiological_respon | 0.29322513 |
| 114 | MP0000249_abnormal_blood_vessel | 0.29137571 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.28903407 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.27750101 |
| 117 | MP0002796_impaired_skin_barrier | 0.26971711 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.26740911 |
| 119 | MP0005023_abnormal_wound_healing | 0.26589437 |
| 120 | MP0001881_abnormal_mammary_gland | 0.26253248 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.26128901 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.26097718 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.25536013 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.24112028 |
| 125 | MP0003959_abnormal_lean_body | 0.23977032 |
| 126 | MP0010386_abnormal_urinary_bladder | 0.23323368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.61171530 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.19878206 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.18454299 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.63209380 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60498039 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.27943705 |
| 7 | Xanthomatosis (HP:0000991) | 6.24035998 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.50901902 |
| 9 | Complement deficiency (HP:0004431) | 5.24247842 |
| 10 | Joint hemorrhage (HP:0005261) | 4.78555271 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.67730154 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55803097 |
| 13 | Epidermoid cyst (HP:0200040) | 4.48605762 |
| 14 | Hyperammonemia (HP:0001987) | 4.46200813 |
| 15 | Ketosis (HP:0001946) | 4.38884739 |
| 16 | Hyperglycinemia (HP:0002154) | 4.38640003 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26462528 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.23025867 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18647337 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.18306529 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.12085470 |
| 22 | Fat malabsorption (HP:0002630) | 4.05698474 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03508487 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02295523 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.90812768 |
| 26 | Hyperglycinuria (HP:0003108) | 3.89040783 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86221302 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.86221302 |
| 29 | Abnormality of complement system (HP:0005339) | 3.81080496 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79397793 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65985483 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.51708631 |
| 33 | Nephritis (HP:0000123) | 3.42407401 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38160243 |
| 35 | Ketoacidosis (HP:0001993) | 3.31265062 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30209929 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.28851522 |
| 38 | Spontaneous abortion (HP:0005268) | 3.15462748 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.06817517 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05242745 |
| 41 | Steatorrhea (HP:0002570) | 3.03746728 |
| 42 | Myocardial infarction (HP:0001658) | 3.01396750 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.97659519 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.97621469 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.94212074 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.92679584 |
| 47 | Neonatal hypoglycemia (HP:0001998) | 2.86762878 |
| 48 | Skin nodule (HP:0200036) | 2.83505271 |
| 49 | Metabolic acidosis (HP:0001942) | 2.76188720 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.74871376 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.66924078 |
| 52 | Gout (HP:0001997) | 2.63181495 |
| 53 | Fair hair (HP:0002286) | 2.57982066 |
| 54 | Vascular calcification (HP:0004934) | 2.57876942 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.57155562 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57155562 |
| 57 | Lethargy (HP:0001254) | 2.56107248 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.55507621 |
| 59 | Purpura (HP:0000979) | 2.54388520 |
| 60 | Mitral stenosis (HP:0001718) | 2.52148142 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.45668254 |
| 62 | Acanthocytosis (HP:0001927) | 2.42702434 |
| 63 | Late onset (HP:0003584) | 2.41653491 |
| 64 | Irritability (HP:0000737) | 2.41014649 |
| 65 | Cholelithiasis (HP:0001081) | 2.36160592 |
| 66 | Glomerulonephritis (HP:0000099) | 2.35152731 |
| 67 | Spastic diplegia (HP:0001264) | 2.34769208 |
| 68 | Amyloidosis (HP:0011034) | 2.34606603 |
| 69 | Cerebral edema (HP:0002181) | 2.33370214 |
| 70 | Malnutrition (HP:0004395) | 2.31459144 |
| 71 | Neonatal onset (HP:0003623) | 2.29530420 |
| 72 | Arthropathy (HP:0003040) | 2.28003722 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.27564853 |
| 74 | Pulmonary embolism (HP:0002204) | 2.26672517 |
| 75 | Gingival bleeding (HP:0000225) | 2.23949801 |
| 76 | Cholecystitis (HP:0001082) | 2.23408946 |
| 77 | Abnormal gallbladder physiology (HP:0012438) | 2.23408946 |
| 78 | Enlarged kidneys (HP:0000105) | 2.21077898 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20256839 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.19101204 |
| 81 | Menorrhagia (HP:0000132) | 2.18523048 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.18341424 |
| 83 | Brushfield spots (HP:0001088) | 2.17409941 |
| 84 | Pancreatitis (HP:0001733) | 2.13266843 |
| 85 | Abnormality of the Achilles tendon (HP:0005109) | 2.11550718 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.11074079 |
| 87 | Esophageal varix (HP:0002040) | 2.09486971 |
| 88 | Opisthotonus (HP:0002179) | 2.08984946 |
| 89 | Thrombophlebitis (HP:0004418) | 2.07886283 |
| 90 | Vomiting (HP:0002013) | 2.05970902 |
| 91 | Symptomatic seizures (HP:0011145) | 2.05886017 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.05497694 |
| 93 | Glycosuria (HP:0003076) | 2.01841546 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 2.01841546 |
| 95 | Retinal atrophy (HP:0001105) | 2.00093473 |
| 96 | Hyperglycemia (HP:0003074) | 1.99621684 |
| 97 | Osteomalacia (HP:0002749) | 1.98534052 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 1.98301121 |
| 99 | Rickets (HP:0002748) | 1.95958939 |
| 100 | Alkalosis (HP:0001948) | 1.92766731 |
| 101 | Poikilocytosis (HP:0004447) | 1.92309079 |
| 102 | Reduced antithrombin III activity (HP:0001976) | 1.91398448 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 1.91283338 |
| 104 | Renal cortical cysts (HP:0000803) | 1.90738809 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88985931 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.88978181 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86203292 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.85942172 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.85942172 |
| 110 | Atrioventricular block (HP:0001678) | 1.83882669 |
| 111 | Abnormal cartilage morphology (HP:0002763) | 1.82413893 |
| 112 | Hypothermia (HP:0002045) | 1.81519241 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.81505628 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 1.80463498 |
| 115 | Bile duct proliferation (HP:0001408) | 1.80463498 |
| 116 | Gangrene (HP:0100758) | 1.80307015 |
| 117 | Increased serum ferritin (HP:0003281) | 1.78637522 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.78208662 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.78078326 |
| 120 | Acute hepatic failure (HP:0006554) | 1.77235871 |
| 121 | Joint swelling (HP:0001386) | 1.76968259 |
| 122 | Generalized hypopigmentation of hair (HP:0011358) | 1.75033001 |
| 123 | Status epilepticus (HP:0002133) | 1.74892077 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.70348115 |
| 125 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.65064742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.71646623 |
| 2 | ERN1 | 5.08692232 |
| 3 | SIK1 | 4.62292588 |
| 4 | FGFR4 | 4.61600186 |
| 5 | INSRR | 3.96893152 |
| 6 | TAOK3 | 3.40705099 |
| 7 | ERBB4 | 2.92050247 |
| 8 | PASK | 2.53653587 |
| 9 | NTRK3 | 2.24807992 |
| 10 | FLT3 | 2.13351659 |
| 11 | WNK3 | 2.12581903 |
| 12 | MAP2K4 | 2.08532253 |
| 13 | WNK4 | 2.01922262 |
| 14 | MAPK15 | 1.98168970 |
| 15 | PDK2 | 1.91059536 |
| 16 | PKN2 | 1.85602127 |
| 17 | MAPK11 | 1.82970918 |
| 18 | TRIB3 | 1.81297863 |
| 19 | MST1R | 1.79825560 |
| 20 | TNK2 | 1.78054288 |
| 21 | PIK3CG | 1.66613546 |
| 22 | PTK6 | 1.65483248 |
| 23 | LATS1 | 1.63443268 |
| 24 | TYK2 | 1.54636364 |
| 25 | NLK | 1.51678286 |
| 26 | STK16 | 1.51597115 |
| 27 | MUSK | 1.47963438 |
| 28 | DAPK2 | 1.45374028 |
| 29 | FRK | 1.25699480 |
| 30 | ABL2 | 1.25304240 |
| 31 | JAK2 | 1.25089915 |
| 32 | NEK9 | 1.15801965 |
| 33 | KDR | 1.14433915 |
| 34 | HIPK2 | 1.14350943 |
| 35 | FGFR2 | 1.10322171 |
| 36 | MAP3K7 | 1.05995633 |
| 37 | PINK1 | 1.05905125 |
| 38 | PRKAA2 | 1.05661804 |
| 39 | ERBB2 | 1.02097875 |
| 40 | EPHA3 | 0.98449185 |
| 41 | JAK1 | 0.97992763 |
| 42 | MAP3K10 | 0.95039988 |
| 43 | PRKACA | 0.92983125 |
| 44 | PRKG1 | 0.91793012 |
| 45 | ADRBK2 | 0.91633359 |
| 46 | TBK1 | 0.91065863 |
| 47 | MET | 0.90276695 |
| 48 | PRKCZ | 0.88296728 |
| 49 | DYRK1B | 0.87902988 |
| 50 | MAP3K14 | 0.85241962 |
| 51 | TRPM7 | 0.84832212 |
| 52 | EPHB1 | 0.84277556 |
| 53 | MAP2K3 | 0.83138593 |
| 54 | MAP4K2 | 0.82969946 |
| 55 | MAPK4 | 0.82947710 |
| 56 | GRK6 | 0.81903421 |
| 57 | IRAK3 | 0.80882111 |
| 58 | CSNK1D | 0.80631631 |
| 59 | MAP3K3 | 0.80595428 |
| 60 | STK38L | 0.78257464 |
| 61 | CAMK1D | 0.76348333 |
| 62 | PRKACG | 0.74868698 |
| 63 | PTK2 | 0.74062801 |
| 64 | CSK | 0.72466809 |
| 65 | STK38 | 0.71669888 |
| 66 | CDK6 | 0.70480763 |
| 67 | PRKAA1 | 0.70060411 |
| 68 | CAMK2G | 0.69939058 |
| 69 | TIE1 | 0.69557408 |
| 70 | GSK3A | 0.69467418 |
| 71 | MAP3K11 | 0.66988878 |
| 72 | MAP3K4 | 0.66506514 |
| 73 | OXSR1 | 0.65603578 |
| 74 | CHUK | 0.61850067 |
| 75 | MAPK12 | 0.59352048 |
| 76 | PRKCE | 0.58184037 |
| 77 | FER | 0.57080853 |
| 78 | SGK3 | 0.56352703 |
| 79 | PDPK1 | 0.54846107 |
| 80 | IKBKE | 0.53618857 |
| 81 | SGK1 | 0.53484837 |
| 82 | MAP2K6 | 0.52034117 |
| 83 | STK39 | 0.50594375 |
| 84 | ACVR1B | 0.49396444 |
| 85 | RIPK1 | 0.49329164 |
| 86 | MAP3K1 | 0.49277675 |
| 87 | MAPK7 | 0.49195952 |
| 88 | IKBKB | 0.48932691 |
| 89 | KIT | 0.48049166 |
| 90 | FGFR3 | 0.47973990 |
| 91 | PHKG2 | 0.47817034 |
| 92 | PHKG1 | 0.47817034 |
| 93 | PRKCB | 0.46863106 |
| 94 | CSNK1G1 | 0.45348869 |
| 95 | PRKACB | 0.45307429 |
| 96 | BLK | 0.45294810 |
| 97 | PRKCQ | 0.43366948 |
| 98 | MTOR | 0.43346440 |
| 99 | TGFBR2 | 0.43299144 |
| 100 | CAMKK2 | 0.42997124 |
| 101 | SGK2 | 0.42893162 |
| 102 | MAP3K2 | 0.42164657 |
| 103 | IGF1R | 0.42032888 |
| 104 | ICK | 0.41851838 |
| 105 | CSNK1A1 | 0.40891082 |
| 106 | CAMK2D | 0.39240875 |
| 107 | RPS6KA3 | 0.38835686 |
| 108 | IRAK1 | 0.38356459 |
| 109 | MAP2K1 | 0.38263558 |
| 110 | PKN1 | 0.37786368 |
| 111 | PRKCG | 0.37033336 |
| 112 | GRK1 | 0.36998374 |
| 113 | PAK3 | 0.36572078 |
| 114 | CAMK4 | 0.36034326 |
| 115 | CSF1R | 0.35759948 |
| 116 | CSNK2A1 | 0.35532060 |
| 117 | MAPKAPK3 | 0.34729516 |
| 118 | RET | 0.34706642 |
| 119 | CSNK2A2 | 0.34686661 |
| 120 | SGK223 | 0.34006444 |
| 121 | SGK494 | 0.34006444 |
| 122 | CAMK1G | 0.32710723 |
| 123 | MAP2K2 | 0.32587219 |
| 124 | CDK4 | 0.31873609 |
| 125 | PDGFRA | 0.30527430 |
| 126 | EPHA4 | 0.29463688 |
| 127 | EGFR | 0.28463691 |
| 128 | PDK1 | 0.27598377 |
| 129 | MAP3K5 | 0.27041247 |
| 130 | CSNK1G2 | 0.26811542 |
| 131 | PIK3CA | 0.26066694 |
| 132 | MAP3K13 | 0.25754546 |
| 133 | CSNK1A1L | 0.25487110 |
| 134 | MAP3K6 | 0.25241541 |
| 135 | PRKCA | 0.25188286 |
| 136 | CSNK1G3 | 0.22929097 |
| 137 | IRAK2 | 0.22765788 |
| 138 | AKT3 | 0.21877506 |
| 139 | TAOK2 | 0.21605466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52659428 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44470982 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30282940 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29067356 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01232639 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.77282502 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77262207 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67577952 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61327201 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53289204 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51131415 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41111429 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22956692 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19932071 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10708095 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10330254 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96483041 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89441056 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87372608 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86784648 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85602127 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85109953 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80779902 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77112149 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74602569 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72484602 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72008333 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69413534 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66672192 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64720768 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63886845 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57689281 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57427963 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52400623 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50520775 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49389226 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47776893 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47412972 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47401289 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36147353 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31533870 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31420429 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29948279 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28563032 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.24827847 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16851909 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15874183 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14973116 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07480599 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03295243 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98493208 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96767085 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95563562 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94942344 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93402175 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85937974 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.85588385 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84929282 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84332869 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76943426 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68042541 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65944732 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62077479 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53267768 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49790299 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49272956 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48910921 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46493855 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.39419563 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.33882800 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30477089 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29738369 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.29253675 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24929783 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23244998 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23213138 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18138618 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16184525 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13597371 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.11478534 |
| 81 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08684251 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04601778 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2125569 |
| 84 | Protein export_Homo sapiens_hsa03060 | -0.2104618 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2060621 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2022570 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1874467 |
| 88 | Lysosome_Homo sapiens_hsa04142 | -0.1829101 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | -0.1744994 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1704791 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1697374 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1681235 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1547580 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1536419 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1322592 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1295069 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1263166 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | -0.1224639 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1008502 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0880731 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0803509 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0709733 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0694765 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0667609 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0663239 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0445115 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0374718 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0340726 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0221584 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0122475 |

